TDC
CRHM

Thompson Davis & Co’s CRH Medical Corporation CRHM Stock Holding History

Thompson Davis & Co’s Portfolio CRHM Stock Details CRHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-750
Closed -$6K – 1218
2017
Q1 		$6K Buy
+750
New +$5.19K 0.01% 864

Other funds holding CRHM

Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

Thompson Davis & Co's CRHM Position: Q2 2017 in Review

Thompson Davis & Co sold out of CRH Medical Corporation (CRHM) in Q2 2017, closing a stake of 750 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in CRHM in Q1 2017 and held it in 1 quarter. The position peaked at $6K in Q1 2017. 59 funds tracked by Wall St. Rank hold CRHM as of Q2 2017.

  • Thompson Davis & Co reported no remaining CRH Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 750 CRH Medical Corporation shares in Q2 2017, an estimated $6K.
  • Thompson Davis & Co first reported a position in CRH Medical Corporation in Q1 2017 and held it in 1 quarter.
  • Thompson Davis & Co's CRH Medical Corporation position peaked at $6K in Q1 2017.
  • 59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.